Elucidating the Molecular and Cellular Mechanism Underlying Cancer Cachexia

Elucidating the Molecular and Cellular Mechanism Underlying Cancer Cachexia

Bibliographic Details
Main Author:	He, Wei
Language:	English
Published:	The Ohio State University / OhioLINK 2013
Subjects:	Biology Cellular Biology Molecular Biology Genetics Cancer cachexia Pax7 NF-kB muscle regeneration microvesicles miRNA apoptosis myogenic program cachexia C-26
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1385054981

Similar Items

Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia
by: Chunxiao Miao, et al.
Published: (2021-06-01)

Dissecting the Roles of the Non-canonical NF-kB signaling in the Pathogenesis of Lymphoma and Autoimmunity
by: Wang, Zhe
Published: (2008)

Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs
by: Rui Chen, et al.
Published: (2020-09-01)

The Role of CCAAT/Enhancer Binding Protein Beta (C/EBPβ) in Skeletal Muscle Satellite Cells after Injury and in Cancer Cachexia
by: Marchildon, François
Published: (2015)

Identification of microRNAs in skeletal muscle associated with lung cancer cachexia
by: Wouter R.P.H. van deWorp, et al.
Published: (2020-04-01)

miRNA-130a Significantly Improves Accuracy of SGA Nutritional Assessment Tool in Prediction of Malnutrition and Cachexia in Radiotherapy-Treated Head and Neck Cancer Patients
by: Tomasz Powrózek, et al.
Published: (2018-08-01)

Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs
by: Roberta Belli, et al.
Published: (2021-08-01)

Displaced Myonuclei in Cancer Cachexia Suggest Altered Innervation
by: Nissrine Daou, et al.
Published: (2020-02-01)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2020-02-01)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2019-02-01)

Translating the Anti-Tumor/Anti-Cachectic Activity of AR-42, a Novel HDAC Inhibitor, into Pancreatic Cancer Therapy
by: Henderson, Sally E.
Published: (2017)

The Role of microRNA in Cancer Cachexia and Muscle Wasting: A Review Article
by: Noorwati Sutandyo
Published: (2021-03-01)

Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle
by: Gabriela S. de Castro, et al.
Published: (2019-08-01)

Metabolic Biomarkers for the Early Detection of Cancer Cachexia
by: Thomas M. O’Connell, et al.
Published: (2021-09-01)

Cachexia syndrome: The present state of the problem and importance in clinical practice
by: M F Ballyuzek, et al.
Published: (2015-08-01)

Cancer Cachexia
by: Tanadech Dechaphunkul
Published: (2011-10-01)

Role of Exosomal MicroRNAs and myomiRs in the Development of Cancer Cachexia-Associated Muscle Wasting
by: Rodolfo Marinho, et al.
Published: (2018-01-01)

Silver linings on the horizon: highlights from the 10th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2018-02-01)

Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
by: Jeffrey S. Damrauer, et al.
Published: (2018-06-01)

Diabetic neuropathic cachexia in a young female
by: Saumik Datta, et al.
Published: (2013-01-01)

Biomarkers for Cancer Cachexia: A Mini Review
by: Zhipeng Cao, et al.
Published: (2021-04-01)

Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia
by: Shanshan Lu, et al.
Published: (2021-06-01)

Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia
by: Sara Donzelli, et al.
Published: (2020-04-01)

Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives
by: Anastasia Kottorou, et al.
Published: (2021-07-01)

One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA
by: Susan T Arthur, et al.
Published: (2014-07-01)

Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
by: Alex R. Straughn, et al.
Published: (2019-11-01)

FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
by: Daria Neyroud, et al.
Published: (2021-04-01)

Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta‐analysis
by: Rafaela C.E. Santo, et al.
Published: (2018-10-01)

IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway
by: Dong Liu, et al.
Published: (2019-03-01)

Inflamma-miR-21 Negatively Regulates Myogenesis during Ageing
by: Maria Borja-Gonzalez, et al.
Published: (2020-04-01)

Pathogenetic aspects of cachexia
by: Irina S. Klochkova, et al.
Published: (2020-06-01)

Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia
by: Dean G. Campelj, et al.
Published: (2021-05-01)

Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia
by: James P. White, et al.
Published: (2013-11-01)

Group I Paks support muscle regeneration and counteract cancer‐associated muscle atrophy
by: Andrea Cerquone Perpetuini, et al.
Published: (2018-08-01)

Cachexia as a common characteristic in multiple chronic disease
by: Nadja Scherbakov, et al.
Published: (2018-12-01)

Commentary: Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis
by: Thomas J Wilkinson
Published: (2015-12-01)

Cancer anorexia-cachexia syndrome
by: S Ruengdit, et al.
Published: (2009-12-01)

Pancreatic cancer cachexia: A review of mechanisms and therapeutics
by: Carlyn Rose Tan, et al.
Published: (2014-03-01)

Differential Diagnosis of Cachexia and Refractory Cachexia and the Impact of Appropriate Nutritional Intervention for Cachexia on Survival in Terminal Cancer Patients
by: Nobuhisa Nakajima
Published: (2021-03-01)

A prospective study examining cachexia predictors in patients with incurable cancer
by: Ola Magne Vagnildhaug, et al.
Published: (2019-06-01)